Insider Trading disclosures for BioAffinity Technologies Inc

The latest disclosure was made by Maria Zannes in BioAffinity Technologies Inc where a trade of 37,037 Common Stock done was reported to US exchanges on Jan. 10, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Show

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Maria Zannes	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	37,037	280,359	-		0	Common Stock
J. Michael Edwards	VP and CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	6,172	120,128	-		0	Common Stock
Steven Girgenti	Director, Executive Chairman	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	14,814	1,080,062	-		0	Common Stock
Timothy P. Zannes	Secretary, EVP, Gen. Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	8,641	54,765	-		0	Common Stock
Xavier Trinidad Reveles	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	21,604	41,943	-		0	Common Stock
J. Michael Edwards	VP and CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Nov 2024	100,000	113,956	-		0	Common Stock
Peter S. Knight	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jul 2024	33,784	117,455	-		0	Common Stock
Stuart Diamond	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jul 2024	33,784	99,088	-		0	Common Stock
Maria Zannes	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jul 2024	33,784	243,322	-		0	Common Stock
Steven Girgenti	Director, Executive Chairman	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jul 2024	33,784	1,065,248	-		0	Common Stock
Robert A. Anderson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jul 2024	33,784	163,936	-		0	Common Stock
Gary Rubin	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jul 2024	33,784	146,597	-		0	Common Stock
Roby P. Joyce	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jul 2024	33,784	66,615	-		0	Common Stock
Jamie Platt	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jul 2024	33,784	54,748	-		0	Common Stock
Peter S. Knight	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2024	8,296	83,671	-		0	Common Stock
Stuart Diamond	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2024	8,296	65,304	-		0	Common Stock
Maria Zannes	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2024	8,296	209,538	-		0	Common Stock
Steven Girgenti	Director, Executive Chairman	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2024	8,296	1,031,464	-		0	Common Stock
Robert A. Anderson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2024	8,296	130,152	-		0	Common Stock
Gary Rubin	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2024	8,296	112,813	-		0	Common Stock
Roby P. Joyce	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2024	8,296	32,831	-		0	Common Stock
Jamie Platt	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2024	8,296	20,964	-		0	Common Stock
Maria Zannes	President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Apr 2024	64,848	0	-		-	Stock Option (right to buy)
Maria Zannes	President & CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.65 per share.	08 Apr 2024	28,264	201,242	-	2.7	74,900	Common Stock
Maria Zannes	President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.16 per share.	08 Apr 2024	64,848	229,506	-	1.2	75,224	Common Stock
Timothy P. Zannes	Secretary, EVP, Gen. Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.16 per share.	04 Apr 2024	64,848	75,155	-	1.2	75,224	Common Stock
Timothy P. Zannes	Secretary, EVP, Gen. Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	04 Apr 2024	64,848	0	-		-	Stock Option (right to buy)
Timothy P. Zannes	Secretary, EVP, Gen. Counsel	Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.58 per share.	04 Apr 2024	29,031	46,124	-	2.6	74,900	Common Stock
Steven Girgenti	Director	Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.24 per share.	03 Apr 2024	33,438	1,023,168	-	2.2	74,901	Common Stock
Steven Girgenti	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Apr 2024	64,848	0	-		-	Stock Option (right to buy)
Steven Girgenti	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.16 per share.	03 Apr 2024	64,848	1,056,606	-	1.2	75,224	Common Stock
Robert A. Anderson	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.15 per share.	26 Feb 2024	64,848	121,856	-	1.2	74,899	Common Stock
Robert A. Anderson	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Feb 2024	64,848	0	-		-	Stock Option (right to buy)
Steven Girgenti	Director, Executive Chairman	Grant, award, or other acquisition of securities at price $ 1.52 per share.	16 Feb 2024	39,474	991,758	-	1.5	60,000	Common Stock
Michael Dougherty	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2024	31,847	84,203	-		0	Common Stock
Xavier Trinidad Reveles	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2024	16,720	20,339	-		0	Common Stock
Timothy P. Zannes	Secretary, EVP, Gen. Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2024	6,688	10,307	-		0	Common Stock
Vivienne Rebel	Chief Sci. & Med. Officer, EVP	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2024	31,847	46,228	-		0	Common Stock
Girgenti Steven	Director, Executive Chairman	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2024	11,943	952,284	-		0	Common Stock
Zannes Maria	Director, President, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2024	23,885	164,658	-		0	Common Stock
Jamie Platt	Director	Grant, award, or other acquisition of securities at price $ 1.48 per share.	01 Jan 2024	12,668	12,668	-	1.5	18,749	Common Stock
Y. Meghji Mohsin	Director	Grant, award, or other acquisition of securities at price $ 1.58 per share.	01 Oct 2023	11,867	109,737	-	1.6	18,750	Common Stock
Girgenti Steven	Director, Executive Chairman	Grant, award, or other acquisition of securities at price $ 1.58 per share.	01 Oct 2023	11,867	927,673	-	1.6	18,750	Common Stock
Maria Zannes	Director, President, CEO	Grant, award, or other acquisition of securities at price $ 1.48 per share.	01 Oct 2023	12,668	140,773	-	1.5	18,749	Common Stock
Steven Girgenti	Director, Executive Chairman	Grant, award, or other acquisition of securities at price $ 1.48 per share.	01 Oct 2023	12,668	940,341	-	1.5	18,749	Common Stock
Diamond Stuart	Director	Grant, award, or other acquisition of securities at price $ 1.58 per share.	01 Oct 2023	11,867	44,340	-	1.6	18,750	Common Stock
Roby P. Joyce	Director	Grant, award, or other acquisition of securities at price $ 1.48 per share.	01 Oct 2023	12,668	24,535	-	1.5	18,749	Common Stock
Roby P. Joyce	Director	Grant, award, or other acquisition of securities at price $ 1.58 per share.	01 Oct 2023	11,867	11,867	-	1.6	18,750	Common Stock
Gary Rubin	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 1.58 per share.	01 Oct 2023	11,867	91,849	-	1.6	18,750	Common Stock
Peter S. Knight	Director	Grant, award, or other acquisition of securities at price $ 1.58 per share.	01 Oct 2023	11,867	62,707	-	1.6	18,750	Common Stock

Showing 1 to 50 of 150 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

New 52W Low in past week

Insider Trading disclosures for BioAffinity Technologies Inc

The latest disclosure was made by Maria Zannes in BioAffinity Technologies Inc where a trade of 37,037 Common Stock done was reported to US exchanges on Jan. 10, 2025.

Screeners based on Insider Trading and SAST parameters